Organigram (NASDAQ:OGI) Issues Quarterly Earnings Results

Organigram (NASDAQ:OGI) issued its earnings results on Wednesday. The company reported ($0.04) EPS for the quarter, missing the consensus estimate of ($0.03) by ($0.01), Zacks reports. Organigram had a negative return on equity of 16.76% and a negative net margin of 45.57%.

Organigram Price Performance

OGI traded up $0.01 on Wednesday, reaching $1.62. 346,916 shares of the company traded hands, compared to its average volume of 929,752. Organigram has a 52-week low of $1.21 and a 52-week high of $2.91. The company has a market cap of $204.37 million, a price-to-earnings ratio of -4.12 and a beta of 1.02. The stock’s 50 day moving average price is $1.63 and its 200-day moving average price is $1.68.

About Organigram

Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.